GLS1 is positively regulated by c‐Myc and correlates with tumor growth and malignancy, whereas GLS2 is positively regulated by p53 and inhibits the PI3K/AKT pathway to hinder tumor growth [70]. The gene discussed is AKT1; the disease is neoplasm.